DI IASIO, Maria Grazia
 Distribuzione geografica
Continente #
NA - Nord America 3.982
AS - Asia 1.805
EU - Europa 899
SA - Sud America 316
Continente sconosciuto - Info sul continente non disponibili 38
AF - Africa 34
OC - Oceania 5
AN - Antartide 1
Totale 7.080
Nazione #
US - Stati Uniti d'America 3.910
SG - Singapore 682
CN - Cina 475
BR - Brasile 253
VN - Vietnam 222
UA - Ucraina 184
DE - Germania 165
GB - Regno Unito 127
HK - Hong Kong 124
TR - Turchia 112
IT - Italia 109
FI - Finlandia 64
SE - Svezia 60
FR - Francia 52
RU - Federazione Russa 40
BD - Bangladesh 38
CA - Canada 36
IN - India 35
JP - Giappone 28
NL - Olanda 28
AR - Argentina 25
MX - Messico 20
ID - Indonesia 17
PL - Polonia 16
BE - Belgio 13
CO - Colombia 10
ES - Italia 10
IQ - Iraq 10
PK - Pakistan 10
ZA - Sudafrica 10
EC - Ecuador 7
LT - Lituania 7
PH - Filippine 7
IL - Israele 6
PY - Paraguay 6
VE - Venezuela 6
AU - Australia 5
CL - Cile 5
DZ - Algeria 5
MA - Marocco 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
HN - Honduras 4
IR - Iran 4
JM - Giamaica 4
JO - Giordania 4
SA - Arabia Saudita 4
EG - Egitto 3
MY - Malesia 3
RS - Serbia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
CH - Svizzera 2
HR - Croazia 2
KE - Kenya 2
KG - Kirghizistan 2
KR - Corea 2
OM - Oman 2
PE - Perù 2
PT - Portogallo 2
RO - Romania 2
TG - Togo 2
TW - Taiwan 2
AL - Albania 1
AQ - Antartide 1
AT - Austria 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EE - Estonia 1
GI - Gibilterra 1
GR - Grecia 1
GT - Guatemala 1
KZ - Kazakistan 1
LY - Libia 1
MD - Moldavia 1
MG - Madagascar 1
MN - Mongolia 1
MT - Malta 1
NP - Nepal 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.043
Città #
Ashburn 438
Fairfield 408
Singapore 399
Woodbridge 385
San Jose 253
Houston 237
Jacksonville 199
Chandler 169
Beijing 164
Santa Clara 145
Ann Arbor 140
Seattle 137
Hong Kong 123
Wilmington 122
Cambridge 104
Council Bluffs 86
Ho Chi Minh City 84
Izmir 66
New York 64
Los Angeles 60
Dallas 58
Hanoi 54
Nanjing 47
Munich 41
Princeton 40
San Diego 39
Lauterbourg 33
Ferrara 32
Boardman 28
Tokyo 28
São Paulo 25
Shanghai 22
Brooklyn 21
Orem 21
Milan 20
Falls Church 18
Montreal 17
Nanchang 16
Tianjin 16
Turku 16
Mexico City 15
Amsterdam 14
Buffalo 14
Chicago 14
Changsha 13
London 13
Poplar 13
Warsaw 13
Brussels 12
Hefei 12
Shenyang 12
Denver 11
Hebei 11
Helsinki 11
San Mateo 11
Chennai 10
Dearborn 10
Haiphong 10
Da Nang 9
Atlanta 8
Manchester 8
Boston 7
Columbus 7
Jakarta 7
Jiaxing 7
Mumbai 7
Norwalk 7
Orange 7
Philadelphia 7
San Francisco 7
Stockholm 7
Washington 7
Zhengzhou 7
Ankara 6
Augusta 6
Dronten 6
Jinan 6
Phoenix 6
The Dalles 6
Verona 6
Auburn Hills 5
Baghdad 5
Belo Horizonte 5
Bremen 5
Guarulhos 5
Hải Dương 5
Johannesburg 5
Kunming 5
Leawood 5
Medellín 5
Miami 5
Mountain View 5
Porto Alegre 5
Amman 4
Bologna 4
Brno 4
Bắc Ninh 4
Delhi 4
Dhaka 4
Frankfurt am Main 4
Totale 4.838
Nome #
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 269
Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells 262
Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70 232
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 225
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) 223
TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release 220
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 217
Mesenchymal stem cells-derived vascular smooth muscle cells release abundant levels of osteoprotegerin 216
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 214
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 210
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 210
HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: A potential molecular mechanism to escape TRAIL cytotoxicity 199
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells 193
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells 192
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells 185
Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma 180
Reduced expression of cell cycle-associated genes in B lymphocytes purified from the peripheral blood of early-stage B chronic lymphocytic leukaemia patients 178
Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms 177
Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages 173
C reactive protein down-regulates TNF-related apoptosis inducing ligand expression in human peripheral monocytes via an Egr-1 dependent pathway. 171
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 168
Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women 164
Exposure of B cell chronic lymphocytic leukemia (B-CLL) cells to Nutlin-3 induces a characteristic gene expression profile, which correlates with Nutlin-3-mediated cytotoxicity 164
TNFRSF11B (tumor necrosis factor receptor superfamily, member 11b) 159
The oncogene DEK promotes leukemic cell survival and is downregulated by both nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells 158
The non-genotoxic activator of the p53 pathway Nutlin-3 shifts the balance between E2F7 and E2F1 transcription factors in leukemic cells 157
The MDM2 inhibitor Nutlins as an innovative therapeutic tool for the treatment of haematological malignancies 157
SOCS1 is significantly up-regulated in Nutlin-3-treated p53 wild-type B chronic lymphocytic leukemia (BCLL) samples and shows an inverse correlation with miR-155 152
Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region 151
Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype. 123
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia 122
Risk of venous thromboembolism and stroke associated with oral contraceptives. Role of congenital thrombophilias 119
Nutlin-3 downregulates the expression of the Oncogene TCL1 in primary B Chronic Lymphocytic Leukemic cells. 118
TNFSF10 (tumor necrosis factor Ligand) surfamily,member 10) 116
miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. 115
Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes 102
null 100
null 98
null 98
null 97
null 89
null 83
null 69
null 55
Totale 7.080
Categoria #
all - tutte 30.675
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.675


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022377 0 0 27 23 22 20 33 22 12 27 52 139
2022/2023398 41 20 20 41 66 57 11 32 54 7 28 21
2023/2024149 23 13 7 3 6 29 8 17 1 4 2 36
2024/2025895 23 21 64 44 122 50 44 38 187 65 135 102
2025/20262.419 259 172 208 314 348 179 243 98 209 256 77 56
2026/2027233 52 119 62 0 0 0 0 0 0 0 0 0
Totale 7.080